Lin CW - Search Results

1

Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.

Lin CW, Miller TR, Witte DG, Bianchi BR, Stashko M, Manelli AM, Frail DE. Lin CW, et al. Mol Pharmacol. 1995 Jan;47(1):131-9. Mol Pharmacol. 1995. PMID: 7838121

2

Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.

Lin CW, Shiosaki K, Miller TR, Witte DG, Bianchi BR, Wolfram CA, Kopecka H, Craig R, Wagenaar F, Nadzan AM. Lin CW, et al. Mol Pharmacol. 1991 Mar;39(3):346-51. Mol Pharmacol. 1991. PMID: 1706470

3

Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).

Lin CW, Holladay MW, Barrett RW, Wolfram CA, Miller TR, Witte D, Kerwin JF Jr, Wagenaar F, Nadzan AM. Lin CW, et al. Mol Pharmacol. 1989 Dec;36(6):881-6. Mol Pharmacol. 1989. PMID: 2601685

4

Cloning and characterization of a truncated dopamine D1 receptor from goldfish retina: stimulation of cyclic AMP production and calcium mobilization.

Frail DE, Manelli AM, Witte DG, Lin CW, Steffey ME, Mackenzie RG. Frail DE, et al. Among authors: lin cw. Mol Pharmacol. 1993 Dec;44(6):1113-8. Mol Pharmacol. 1993. PMID: 8264547

5

Identification and characterization of type A endothelin receptors in MMQ cells.

Wu-Wong JR, Chiou W, Magnuson SR, Witte DG, Lin CW. Wu-Wong JR, et al. Among authors: lin cw. Mol Pharmacol. 1993 Aug;44(2):285-91. Mol Pharmacol. 1993. PMID: 8355666

6

ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease.

Shiosaki K, Jenner P, Asin KE, Britton DR, Lin CW, Michaelides M, Smith L, Bianchi B, Didomenico S, Hodges L, Hong Y, Mahan L, Mikusa J, Miller T, Nikkel A, Stashko M, Witte D, Williams M. Shiosaki K, et al. Among authors: lin cw. J Pharmacol Exp Ther. 1996 Jan;276(1):150-60. J Pharmacol Exp Ther. 1996. PMID: 8558425

7

Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.

Lin CW, Bianchi BR, Miller TR, Stashko MA, Wang SS, Curzon P, Bednarz L, Asin KE, Britton DR. Lin CW, et al. J Pharmacol Exp Ther. 1996 Mar;276(3):1022-9. J Pharmacol Exp Ther. 1996. PMID: 8786531

8

Characterization of the novel CCK analogs JMV-180, JMV-320, and JMV-332 in H345 cells.

Witte DG, Nadzan AM, Martinez J, Rodriguez M, Lin CW. Witte DG, et al. Among authors: lin cw. Peptides. 1992 Nov-Dec;13(6):1227-32. doi: 10.1016/0196-9781(92)90033-y. Peptides. 1992. PMID: 1337381

9

Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N epsilon)-amide residues.

Shiosaki K, Lin CW, Kopecka H, Craig RA, Bianchi BR, Miller TR, Witte DG, Stashko M, Nadzan AM. Shiosaki K, et al. Among authors: lin cw. J Med Chem. 1992 May 29;35(11):2007-14. doi: 10.1021/jm00089a010. J Med Chem. 1992. PMID: 1375964

10

Synthesis and biological activity of CCK heptapeptide analogues. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity in vitro, and appetite suppression in vivo.

Holladay MW, Bennett MJ, Tufano MD, Lin CW, Asin KE, Witte DG, Miller TR, Bianchi BR, Nikkel AL, Bednarz L, et al. Holladay MW, et al. Among authors: lin cw. J Med Chem. 1992 Aug 7;35(16):2919-28. doi: 10.1021/jm00094a001. J Med Chem. 1992. PMID: 1501220

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,131 results

Search Page

Filters